Skip to content
MenuOpen navigation menu

Real moms, real GLP-1 talk

GLP-1 Muscle Loss and Strength Training: What the Scans Actually Showed

How much lean mass people lost in the Wegovy and Zepbound body-scan studies, what that means and doesn't, and the strength and protein plan I would want.

Written by — editorial research, not medical advice
On this page

The short answer

Yes, people on semaglutide and tirzepatide lose some lean mass along with fat, and the trial scans measured it. In the tirzepatide body-scan study, about three quarters of the weight lost was fat and about a quarter was lean mass2. That is not the same as "a quarter of it was muscle," and the best-supported response is strength training plus enough food, not panic.

I went looking for the real numbers because "Ozempic eats your muscle" kept showing up in my feeds. The scans tell a calmer and more useful story.

What the trial scans measured

Both big obesity trials ran a smaller substudy with DEXA scans, the X-ray method that splits the body into fat, lean tissue and bone.

StudyDrugFat mass changeLean mass change
STEP 1 DEXA substudy, 140 people, 68 weeksSemaglutide 2.4 mg (Wegovy)About −19%About −10%
SURMOUNT-1 DEXA substudy, 160 people, 72 weeksTirzepatide (Zepbound)About −34%About −11%

Sources: STEP 11 and the SURMOUNT-1 body-composition analysis2.

In STEP 1, lean mass fell in pounds, but it made up a bigger share of the body at the end than at the start, because fat fell faster1. In SURMOUNT-1, roughly 75% of the loss was fat and 25% lean, and that split looked about the same in the placebo group and across most subgroups, including sex and age2. Nearly three quarters of the people in that substudy were women, which made it feel more relevant to me.

Lean mass is not just muscle

This is the part the scary posts skip. "Lean mass" on a scan includes muscle, organs, water and everything else that isn't fat or bone. Some lean loss is expected with any large weight loss, because a smaller body needs less tissue to carry it.

So I would not read a −10% lean figure as a −10% strength figure. A 2026 study of adults on semaglutide in routine care found skeletal muscle mass fell slightly over a year, from 29.9 to 28.7 kg, yet absolute grip strength held steady and strength relative to body weight improved4. It was a small, single-center look back using bioimpedance, so it's a reason for calm, not proof.

Where it matters more

Of all the GLP-1 side effects in women, lean-tissue loss is one that matters more for some of us than others. If I were in midlife, already losing muscle with age, or worried about bone density, I would raise it at the first visit rather than month six. The menopause transition already shifts body composition, which I wrote about in GLP-1s in perimenopause, and the two effects stack. That is a reason to plan for it, not to avoid treatment.

A review in Diabetes Care put it bluntly: these drugs can take about 10% of lean mass, roughly what a decade or more of aging does3. The same review is the hopeful part, because it found that supervised resistance training lasting more than ten weeks can add about 3 kg of lean mass and about 25% strength3.

The plan I would ask for

Lift something, on purpose. The authors propose tailored resistance exercise as a routine add-on to these drugs3. For a busy mom that might mean bands, dumbbells or bodyweight squats two or three times a week, adjusted for injuries and energy.

Eat enough protein to give it something to build with. A joint advisory from four nutrition and obesity groups suggests 1.2 to 1.6 grams per kilogram a day during active weight loss, or 80 to 120 grams a day as a practical target, and says protein alone is unlikely to protect muscle without strength work5. Hitting that on a small appetite is its own project, and my protein notes cover when kidney history changes the number. Spreading it across small meals is easier than one big plate.

Track function, not just pounds. I would notice whether carrying groceries, climbing stairs or getting off the floor with a toddler feels easier or harder. If I became unusually tired or weak, I would ask for a check rather than push through. Those changes are worth a message even between visits.

A program such as HumeCare+ builds body-composition tracking into its care, though a tracking feature alone doesn't prove anything is being preserved. A home scale's daily swings are mostly water.

What it does and doesn't explain

The shape changes people call "Ozempic butt" come from losing fat and some lean tissue together, but no trial has measured a specific body part. If a plateau shows up, I would not assume lost muscle is the reason, since a GLP-1 plateau has likelier causes. The scale can stall for a lot of ordinary reasons.

I would also want strength habits in place long before stopping a GLP-1 comes up. The Diabetes Care authors suggest that keeping lean mass during treatment could blunt weight regain after stopping, though that is still a proposal rather than a tested result3.

If you feel new weakness, dizziness or can't eat enough to function, call your prescriber before your next dose.

Frequently asked questions

How much muscle do you lose on Wegovy or Zepbound?

The trials measured lean mass, which includes muscle, organs and water. In the STEP 1 scan substudy, lean mass fell about 10% on semaglutide while fat fell about 19%. In the SURMOUNT-1 scan substudy, about 75% of the weight lost on tirzepatide was fat and about 25% was lean mass, a split similar to placebo.

Does strength training prevent muscle loss on a GLP-1?

It is the best-supported option. A 2024 Diabetes Care review found that supervised resistance training lasting more than ten weeks can add about 3 kg of lean mass and about 25% strength, and proposed it as a routine add-on to these drugs. Trials combining it with semaglutide or tirzepatide specifically are still limited.

How much protein should I eat to protect muscle on a GLP-1?

A 2025 joint advisory suggested 1.2 to 1.6 grams per kilogram per day during active weight loss, or 80 to 120 grams a day as a practical target, alongside strength training. Kidney disease and other conditions can change that number, so ask a clinician or dietitian.

Does losing lean mass mean I am getting weaker?

Not necessarily. A 2026 observational study found skeletal muscle mass fell slightly over a year on semaglutide while absolute grip strength was preserved and strength relative to body weight improved. It was small and retrospective, so tracking your own strength and function is still worthwhile.

References

  1. Wilding JPH, Batterham RL, Calanna S, et al.; STEP 1 Study Group (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. https://pubmed.ncbi.nlm.nih.gov/33567185/
  2. Look M, Dunn JP, Kushner RF, et al. (2025). Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab. https://pubmed.ncbi.nlm.nih.gov/39996356/
  3. Locatelli JC, Costa JG, Haynes A, et al. (2024). Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?. Diabetes Care. https://pubmed.ncbi.nlm.nih.gov/38687506/
  4. Filippi-Arriaga F, Comas M, Prats A, et al. (2026). Longitudinal Changes in Body Composition, Adaptive Thermogenesis, and Muscle Strength in Patients with Obesity Treated with Semaglutide. Obes Facts. https://pubmed.ncbi.nlm.nih.gov/42640861/
  5. American College of Lifestyle Medicine, American Society for Nutrition, Obesity Medicine Association and The Obesity Society (2025). Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory. The American Journal of Clinical Nutrition. https://pmc.ncbi.nlm.nih.gov/articles/PMC12264624/

One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. Pregnancy planning and breastfeeding need advice for the exact medicine and formulation. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history.